Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575

The γ-secretase complex is a major therapeutic target for the prevention and treatment of Alzheimer's disease. Previous studies have shown that treatment of young APP mice with specific inhibitors of γ-secretase prevented formation of new plaques. It has not yet been shown directly whether exis...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Alloza, Monica, Subramanian, Meenakshi, Thyssen, Diana, Borrelli, Laura A, Fauq, Abdul, Das, Pritam, Golde, Todd E, Hyman, Bradley T, Bacskai, Brian J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687427/
https://www.ncbi.nlm.nih.gov/pubmed/19419556
http://dx.doi.org/10.1186/1750-1326-4-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687427/
https://www.ncbi.nlm.nih.gov/pubmed/19419556
http://dx.doi.org/10.1186/1750-1326-4-19

Ejemplares similares